跳至主要内容
临床试验/NCT04682288
NCT04682288已完成1 期

An Interventional, Open Label, Non-randomized, Phase Ia Safety and Tolerability Study of Levofloxacin Ocular Implant in Subjects Undergoing Routine Cataract Surgery.

PolyActiva Pty Ltd3 个研究点 分布在 2 个国家目标入组 5 人开始时间: 2021年1月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
5
试验地点
3
主要终点
Endothelial Cell Density

研究概览

简要总结

This is a multi center, open label, interventional study in one eye of 5 subjects scheduled for uncomplicated cataract surgery with administration of a single Levofloxacin Ocular Implant in the posterior sulcus of the surgical eye at the end of cataract surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of cataract in the intent to treat eye
  • Endothelial cell density in the study eye of at least 2000 cells per mm2

排除标准

  • history of ocular inflammation including, macular degeneration, uveitis, macular edema or corneal edema
  • recent surgery in the study eye
  • subjects receiving a glaucoma device in conjunction with cataract surgery
  • subjects with a compromised posterior capsule during surgery
  • corneal disease that prevents effective imaging of endothelium including Fuch's Dystrophy.
  • sensitivity to fluoroquinolones

研究组 & 干预措施

Levofloxacin Ocular Implant

Experimental

Biphasic levofloxacin antibiotic implant

干预措施: Levofloxacin Ocular Implant (Drug)

结局指标

主要结局

Endothelial Cell Density

时间窗: 90 days

Change in number of central corneal endothelial cells per mm2

Intraocular Pressure (IOP)

时间窗: 90 days

Change in IOP measured by Goldmann applenation tonometry

Ocular Inflammation

时间窗: 90 days

Change assessed according to Standardization of Uveitis Nomenclature (SUN) Grading Scale

次要结局

  • Administration procedure(1 week)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验